Yasuo Ono

Prof. Dr. Yasuo Ono

Teikyo University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
PDF file
YOYasuo Ono
Yasuo Ono
TWTakeshi Watanabe
Takeshi Watanabe
KMKaoru Matsumoto
Kaoru Matsumoto
TITadashi Ito
Tadashi Ito
OKOtohiko Kunii
Otohiko Kunii
EGElliot Goldstein
Elliot Goldstein

13 August 2018 in FEBS Letters
Verified
Journal Article
Open access
PDF file
YUYuka Unno
Yuka Unno
YSYoshinori Sato
Yoshinori Sato
HFHayato Fukuda
Hayato Fukuda
KIKohei Ishimura
Kohei Ishimura
HIHiroyuki Ikeda
Hiroyuki Ikeda
YOYasuo Ono
Yasuo Ono
E‐series resolvins are biosynthesized from eicosapentaenoic acid during the resolution phase of acute inflammation and enhance inflammation resolution. However, the role of E‐series resolvins in inflammation resolution is not yet known. Herein, we show that in human polymorphonuclear neutrophils (PMNs), resolvin E1 (RvE1) selectively enhances reactive oxygen species (ROS) generation induced byN‐formylmethionyl‐leucyl‐phenylalanine. The RvE1‐mediated enhancement is eliminated by a pan‐antagonist of leukotriene B4 (LTB4) receptors,LY255283, or anNADPHoxidase inhibitor, diphenyleneiodonium. Thus, RvE1 enhancesNADPHoxidase‐mediatedROSgeneration viaLTB4 receptors. Unlike RvE1, resolvins E2 and E3 do not show such activation ofPMNs. Our findings suggest that RvE1 contributes to regulation ofROSgeneration, in accordance with the inflammatory state of the host.

25 December 2015 in Protein Expression and Purification
Verified
Journal Article
Closed access
TUTakafumi Ueda
Takafumi Ueda
TATeruo Akuta
Teruo Akuta
TKTakane Kikuchi-Ueda
Takane Kikuchi-Ueda
KIKeitaro Imaizumi
Keitaro Imaizumi
YOYasuo Ono
Yasuo Ono

1 November 2017 in Immunobiology
Verified
Journal Article
Closed access
TKTakane Kikuchi-Ueda
Takane Kikuchi-Ueda
GKGo Kamoshida
Go Kamoshida
TUTsuneyuki Ubagai
Tsuneyuki Ubagai
RNRyuichi Nakano
Ryuichi Nakano
ANAkiyo Nakano
Akiyo Nakano
YOYasuo Ono
Yasuo Ono

18 November 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
SNSatoshi Nishida
Satoshi Nishida
NMNaohisa Matsunaga
Naohisa Matsunaga
YKYuta Kamimura
Yuta Kamimura
SIShinobu Ishigaki
Shinobu Ishigaki
TFTaiji Furukawa
Taiji Furukawa
YOYasuo Ono
Yasuo Ono
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.

1 July 2018 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
YUYuka Unno
Yuka Unno
HYHirona Yamamoto
Hirona Yamamoto
STShuto Takatsuki
Shuto Takatsuki
YSYoshinori Sato
Yoshinori Sato
TKTakefumi Kuranaga
Takefumi Kuranaga
TWToshiyuki Wakimoto
Toshiyuki Wakimoto